MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on August 22, 2006; DOI: 10.1124/mol.106.025684


0026-895X/06/7005-1783-1791$20.00
Mol Pharmacol 70:1783-1791, 2006

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.106.025684v1
70/5/1783    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Albizu, L.
Right arrow Articles by Durroux, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Albizu, L.
Right arrow Articles by Durroux, T.

Probing the Existence of G Protein-Coupled Receptor Dimers by Positive and Negative Ligand-Dependent Cooperative Binding

Laura Albizu, Marie-Noëlle Balestre, Christophe Breton, Jean-Philippe Pin, Maurice Manning, Bernard Mouillac, Claude Barberis, and Thierry Durroux

Institut de Génomique Fonctionnelle, Centre National de la Recherche Scientifique Unité Mixte de Recherche 5203, Montpellier, France (L.A., M.-N.B., J.-P.P., B.M., C.B., T.D.); Institut National de la Santé et de la Recherche Médicale U 661, Montpellier, France (L.A., M.-N.B., J.-P.P., B.M., C.B., T.D.); Universités 1 and 2 Montpellier, Montpellier, France (L.A., M.-N.B., J.-P.P., B.M., C.B., T.D.); Laboratoire de Neuroendocrinologie du Développement, Département de Physiologie, Unité Propre de Recherche et de l'Enseignement Supérieur, Equipe d'Accueil 2701, Université des Sciences et Technologies de Lille, Villeneuve d'Ascq, France (C.B.); and Department of Biochemistry and Cancer Biology, Medical University of Ohio, Toledo, Ohio (M.M.)

An increasing amount of ligand binding data on G protein-coupled receptors (GPCRs) is not compatible with the prediction of the simple mass action law. This may be related to the propensity of most GPCRs, if not all, to oligomerize. Indeed, one of the consequences of receptor oligomerization could be a possible cross-talk between the protomers, which in turn could lead to negative or positive cooperative ligand binding. We prove here that this can be demonstrated experimentally. Saturation, dissociation, and competition binding experiments were performed on vasopressin and oxytocin receptors expressed in Chinese hamster ovary or COS-7 cells. Linear, concave, and convex Scatchard plots were then obtained, depending on the ligand used. Moreover, some competition curves exhibited an increase of the radiotracer binding for low concentrations of competitors, suggesting a cooperative binding process. These data demonstrate that various vasopressin analogs display either positive or negative cooperative binding. Because positive cooperative binding cannot be explained without considering receptor as multivalent, these binding data support the concept of GPCR dimerization process. The results, which are in good accordance with the predictions of previous mathematical models, suggest that binding experiments can be used to probe the existence of receptor dimers.


Received April 13, 2006; accepted August 22, 2006

Address correspondence to: Thierry Durroux, Institut de Génomique Fonctionnelle, Centre National de la Recherche Scientifique UMR 5203, 141 rue de la Cardonille, 34094 Montpellier CEDEX 5, France. E-mail: tdurroux{at}igf.cnrs.fr




This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
J. Brea, M. Castro, J. Giraldo, J. F. Lopez-Gimenez, J. F. Padin, F. Quintian, M. I. Cadavid, M. T. Vilaro, G. Mengod, K. A. Berg, et al.
Evidence for Distinct Antagonist-Revealed Functional States of 5-Hydroxytryptamine2A Receptor Homodimers
Mol. Pharmacol., June 1, 2009; 75(6): 1380 - 1391.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
H. Orcel, L. Albizu, S. Perkovska, T. Durroux, C. Mendre, H. Ansanay, B. Mouillac, and A. Rabie
Differential Coupling of the Vasopressin V1b Receptor through Compartmentalization within the Plasma Membrane
Mol. Pharmacol., March 1, 2009; 75(3): 637 - 647.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Damian, S. Mary, A. Martin, J.-P. Pin, and J.-L. Baneres
G Protein Activation by the Leukotriene B4 Receptor Dimer: EVIDENCE FOR AN ABSENCE OF TRANS-ACTIVATION
J. Biol. Chem., July 25, 2008; 283(30): 21084 - 21092.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
X. Rovira, D. Roche, J. Serra, J. Kniazeff, J.-P. Pin, and J. Giraldo
Modeling the Binding and Function of Metabotropic Glutamate Receptors
J. Pharmacol. Exp. Ther., May 1, 2008; 325(2): 443 - 456.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics